Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of … – Nasdaq
|
Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of …
Nasdaq "This partnership brings together our collective experience in Duchenne drug development and Genethon's particular expertise in gene therapy for rare diseases. We look forward to working with Genethon given their knowledge, large infrastructure and … |
